Proteomics International Laboratories Limited logo

Proteomics International Laboratories Limited

ASX:PIQ.AX

Overview | Financials
Company Name Proteomics International Laboratories Limited
Symbol PIQ.AX
Currency AUD
Price 0.6
Market Cap 78,601,799
Dividend Yield 0%
52-week-range 0.55 - 1.4
Industry Biotechnology
Sector Healthcare
CEO Dr. Richard John Lipscombe M.A., MA (Oxford), Ph.D., Ph.D., (London)
Website https://www.proteomics.com.au

An error occurred while fetching data.

About Proteomics International Laboratories Limited

Proteomics International Laboratories Limited operates as a medical technology company with a focus on the area of proteomics. It provides PromarkerD, a predictive test for diabetic kidney disease; and develops diagnostic tests for endometriosis and giardia. The company also offers analytical services, including specialist contract research. Proteomics International Laboratories Ltd

Related Stocks

Vita Life Sciences Limited logo

Vita Life Sciences Limited

VLS.AX

2.15 AUD

SDI Limited logo

SDI Limited

SDI.AX

0.98 AUD

Little Green Pharma Ltd logo

Little Green Pharma Ltd

LGP.AX

0.085 AUD

Kazia Therapeutics Limited logo

Kazia Therapeutics Limited

KZA.AX

0.08 AUD

Prescient Therapeutics Limited logo

Prescient Therapeutics Limited

PTX.AX

0.041 AUD

Universal Biosensors, Inc. logo

Universal Biosensors, Inc.

UBI.AX

0.13 AUD

Financials

Numbers are in millions USD

Numbers are in millions USD